Skip to content
← Back to this collection

PUBLICATIONS · 28767288

Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Sep 10
First author
Kutny MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kutny MA
      type
      Author
    2. name
      Alonzo TA
      type
      Author
    3. name
      Gerbing RB
      type
      Author
    4. name
      Wang YC
      type
      Author
    5. name
      Raimondi SC
      type
      Author
    6. name
      Hirsch BA
      type
      Author
    7. name
      Fu CH
      type
      Author
    8. name
      Meshinchi S
      type
      Author
    9. name
      Gamis AS
      type
      Author
    10. name
      Feusner JH
      type
      Author
    11. name
      Gregory JJ Jr
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kutny MA
      type
      Author
    2. name
      Alonzo TA
      type
      Author
    3. name
      Gerbing RB
      type
      Author
    4. name
      Wang YC
      type
      Author
    5. name
      Raimondi SC
      type
      Author
    6. name
      Hirsch BA
      type
      Author
    7. name
      Fu CH
      type
      Author
    8. name
      Meshinchi S
      type
      Author
    9. name
      Gamis AS
      type
      Author
    10. name
      Feusner JH
      type
      Author
    11. name
      Gregory JJ Jr
      type
      Author
    bibliography ids
    1. nci-bib-86d365c0a7e2db93368c6fd7
    book metadata
    content sha256
    01ae6f6fd7005cf62ef1c4f3d58f5386d4ccb011dcc3fe78e5d7e61fc243b0a9
    document type
    citation
    dois
    1. 10.1200/JCO.2016.71.6183
    electronic publication date
    display
    2017 Aug 2
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28767288
    immutable id
    pubmed:28767288@01ae6f6fd7005cf62ef1c4f3d58f5386d4ccb011dcc3fe78e5d7e61fc243b0a9
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    26
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3021-3029
    volume
    35
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28767288
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      763623fa71e1b22ffa97156d32c770949350714fd11cc06606af9904b48e4d34
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2017 Sep 10
      precision
      day
      year
      2017
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28767288/
      title
      Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.

      Preserved source evidence · Not medical advice